-
Evelo Biosciences Announces Pricing of Public Offering of Common Stock
-
Evelo Biosciences Inc. (EVLO) Announces $50M Proposed Public Offering of Common Stock
-
Evelo Biosciences Announces Proposed Public Offering of Common Stock
-
Evelo Biosciences Announces Proposed Public Offering of Common Stock
-
Evelo Biosciences Inc (EVLO) PT Raised to $18 at BMO Capital
-
Evelo Biosciences Inc. (EVLO) Prices 12M Share Common Offering at $3.75/Sh
-
Evelo Biosciences Announces Pricing of Public Offering of Common Stock
-
Evelo Biosciences Announces Pricing of Public Offering of Common Stock
-
UPDATE: Evelo Biosciences Inc. (EVLO) Announces Proposed $40M Common Share Offering
-
Evelo Biosciences Announces Proposed Public Offering of Common Stock
-
Evelo Biosciences Announces Proposed Public Offering of Common Stock
-
Evelo Biosciences Inc (EVLO) PT Lowered to $24 at BMO Capital
-
Evelo Biosciences to Present at BMO Capital Markets 2018 Prescriptions for Success Healthcare Conference
-
Evelo Biosciences to Present at BMO Capital Markets 2018 Prescriptions for Success Healthcare Conference
-
BMO Capital Starts Evelo Biosciences Inc (EVLO) at Outperform
-
Evelo Biosciences Announces Closing of Initial Public Offering
-
Evelo Biosciences Announces Closing of Initial Public Offering
-
Evelo Biosciences (EVLO) IPO Opens Flat
-
Evelo Biosciences (EVLO) Prices 5.31M Share IPO at $16/Sh
-
Evelo Biosciences Announces Pricing of Initial Public Offering
-
Evelo Biosciences Announces Pricing of Initial Public Offering

